APELLIS PHARMACEUTICALS

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals is an early-stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease. The company is leveraging courageous science, creativity, and compassion to deliver life-changing medicines. They aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. It was founded in 2008 and headquartered in Waltham, Massachusetts, United States.

#SimilarOrganizations #People #Financial #Website #More

APELLIS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2008-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.apellis.com

Total Employee:
101+

Status:
Active

Contact:
502-241-4114

Email Addresses:
[email protected]

Total Funding:
168.53 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box


Similar Organizations

acelrx-pharmaceuticals-logo

AcelRx Pharmaceuticals

AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.

adial-pharmaceuticals-logo

Adial Pharmaceuticals

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

allena-pharmaceuticals-logo

Allena Pharmaceuticals

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

arvinas-logo

Arvinas

Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

beryllium-discovery-logo

Beryllium Discovery

Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.

briacell-therapeutics-logo

BriaCell Therapeutics

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

ceapro-logo

Ceapro

Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.

cerulean-pharma-logo

Cerulean Pharma

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

click-therapeutics-logo

Click Therapeutics

Click Therapeutics delivers safe and effective digital treatments to patients in need.

conatus-pharmaceuticals-logo

Conatus Pharmaceuticals

Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.

corvidia-logo

Corvidia

Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

icosavax-logo

Icosavax

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

innovus-pharmaceuticals-logo

Innovus Pharmaceuticals

Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.

purple-biotech-logo

Purple Biotech

Purple Biotech is an innovative biopharmaceutical drug development company.

vyne-therapeutics-logo

VYNE Therapeutics

VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.

neurana-pharmaceuticals-logo

Neurana Pharmaceuticals

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

novita-pharmaceuticals-logo

Novita Pharmaceuticals

Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.

renovorx-logo

RenovoRx

RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.

rigel-pharmaceuticals-logo

Rigel Pharmaceuticals

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

silver-creek-pharmaceuticals-logo

Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

not_available_image

Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

sunesis-pharmaceuticals-logo

Sunesis Pharmaceuticals

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

theragene-pharmaceuticals-logo

Theragene Pharmaceuticals

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.

zavante-therapeutics-logo

Zavante Therapeutics

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.


Current Advisors List

maha-katabi_image

Maha Katabi Board of Director @ Apellis Pharmaceuticals
Board_member

Current Employees Featured

cedric-francois_image

Cedric Francois
Cedric Francois Co-founder, Chief Executive Officer & President @ Apellis Pharmaceuticals
Co-founder, Chief Executive Officer & President
2010-01-01

pascal-deschatelets_image

Pascal Deschatelets
Pascal Deschatelets Founder & Chief Operating Officer @ Apellis Pharmaceuticals
Founder & Chief Operating Officer

lukas-scheibler_image

Lukas Scheibler
Lukas Scheibler Chief Innovation Officer @ Apellis Pharmaceuticals
Chief Innovation Officer

nur-nicholson_image

Nur Nicholson
Nur Nicholson Chief Technical Operations Officer @ Apellis Pharmaceuticals
Chief Technical Operations Officer

adam-townsend_image

Adam Townsend
Adam Townsend CCO @ Apellis Pharmaceuticals
CCO

timothy-sullivan_image

Timothy Sullivan
Timothy Sullivan CFO @ Apellis Pharmaceuticals
CFO

not_available_image

David O. Watson
David O. Watson General Counsel @ Apellis Pharmaceuticals
General Counsel
2014-01-01

mike-yeadon_image

Mike Yeadon
Mike Yeadon Consultant Acting Chief Scientific Officer @ Apellis Pharmaceuticals
Consultant Acting Chief Scientific Officer

federico-grossi_image

Federico Grossi
Federico Grossi Chief Medical Officer @ Apellis Pharmaceuticals
Chief Medical Officer

janina-hadeler_image

Janina Hadeler
Janina Hadeler EU Medical Communications and Information Lead @ Apellis Pharmaceuticals
EU Medical Communications and Information Lead
2022-04-01

Founder


cedric-francois_image

Cedric Francois

pascal-deschatelets_image

Pascal Deschatelets

Stock Details


Company's stock symbol is NASDAQ:APLS

Acquisitions List

Date Company Article Price
2014-11-20 Potentia Pharmaceuticals Potentia Pharmaceuticals acquired by Apellis Pharmaceuticals N/A

Investors List

solasta-ventures_image

Solasta Ventures

Solasta Ventures investment in Post-IPO Equity - Apellis Pharmaceuticals

venbio_image

venBio Partners

venBio Partners investment in Series E - Apellis Pharmaceuticals

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series E - Apellis Pharmaceuticals

morningside-technology-ventures_image

Morningside Venture Investments

Morningside Venture Investments investment in Series E - Apellis Pharmaceuticals

clough-capital-partners_image

Clough Capital Partners

Clough Capital Partners investment in Series E - Apellis Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series E - Apellis Pharmaceuticals

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series E - Apellis Pharmaceuticals

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series E - Apellis Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series E - Apellis Pharmaceuticals

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series E - Apellis Pharmaceuticals

Official Site Inspections

http://www.apellis.com Semrush global rank: 1.3 M Semrush visits lastest month: 22.6 K

  • Host name: ec2-3-141-146-16.us-east-2.compute.amazonaws.com
  • IP address: 3.141.146.16
  • Location: Columbus United States
  • Latitude: 39.9653
  • Longitude: -83.0235
  • Metro Code: 535
  • Timezone: America/New_York
  • Postal: 43215

Loading ...

More informations about "Apellis Pharmaceuticals" on Search Engine